'No evidence' AstraZeneca jab caused blood clots - UK minister

accreditation
0:00
play article
Subscribers can listen to this article
  • Matt Hancock has urged the British public to take the AstraZeneca Covid-19 vaccine.
  • Some countries have put the brakes on the vaccine after several reports of health risks associated with the jab.
  • Britain has given nearly 25 million people a first dose of a Covid vaccine.


AstraZeneca's Covid vaccine shot is safe and there is no evidence of health risks, the UK's health minister wrote in a newspaper article published on Wednesday, after some EU countries halted rollouts over fears of blood clots.

Matt Hancock urged the British public to take the vaccine even after countries including France, Spain and Germany suspended it.

The European Medicines Agency, which previously approved the jab, is conducting a review of the vaccine but said in the meantime it remained convinced of its benefits.

"There is no evidence that vaccines caused these clots," Hancock wrote in The Sun, stressing that the jab had the backing of the EMA, the World Health Organisation (WHO) and Britain's medicine's regulator.

"More than 11 million doses of the AstraZeneca vaccine have now been administered across the UK," he wrote.

"The rate of reported cases (of clots) among the people vaccinated is lower than what would be expected to happen naturally in the general population."

Britain has given nearly 25 million people a first dose of a Covid vaccine, after starting a mass inoculation programme in December last year.

The AstraZeneca jab, developed with scientists at the University of Oxford, is central to getting the country out of lockdown restrictions and back to normality.

READ HERE | 'Troubling' cases justify AstraZeneca pause - French vaccine chief

London has ordered 100 million doses of the low-cost shot, which has been hailed as a potential gamechanger in the global fightback against the virus.

France and Italy have said they will "promptly restart" giving the jab if the EMA review allows it.

As Britain has surged ahead with its vaccination programme, European countries have been accused of playing politics to distract from their sluggish inoculation rollouts.

AstraZeneca announced in January it could only deliver a third of the 120 million doses initially promised to the 27 EU member states in the first quarter, sparking criticism.

As Europe looks to speed up its immunisation programme, Hancock wrote that this week the UK will get "a boost in supply" that will help accelerate the rollout.

Every adult is now expected to get a first dose of a vaccine by the end of July, he added.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 873 votes
I foresee a second term for Cyril Ramaphosa
83% - 9952 votes
Don’t discount a Zweli Mkhize win
10% - 1155 votes
Vote
Rand - Dollar
18.14
-0.7%
Rand - Pound
20.07
+0.2%
Rand - Euro
17.66
-0.2%
Rand - Aus dollar
11.55
-0.0%
Rand - Yen
0.12
-0.6%
Gold
1,695.26
-1.0%
Silver
20.09
-2.7%
Palladium
2,189.46
-3.2%
Platinum
916.50
-1.0%
Brent Crude
94.42
+1.1%
Top 40
59,280
-0.2%
All Share
65,676
-0.2%
Resource 10
63,294
+0.0%
Industrial 25
79,505
-0.7%
Financial 15
14,072
+0.5%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE